$WEWA
WEWARDS, INC.

2024 Q4 Form 10-Q Financial Statement

#000107997324001405 Filed on October 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $13.43K $32.69K
YoY Change -69.23% -56.15%
Operating Profit -$13.43K -$32.69K
YoY Change -69.23% -56.15%
Interest Expense $132.3K
YoY Change 0.0%
% of Operating Profit
Other Income/Expense, Net -$126.0K -$127.4K
YoY Change -0.05% 0.89%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$139.5K -$160.1K
YoY Change -17.84% -20.28%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 107.5M shares 107.5M shares
Diluted Shares Outstanding 107.5M shares 107.5M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $725.8K $741.6K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $2.537K $187.00
Receivables
Other Receivables
Total Short-Term Assets $728.4K $741.7K
YoY Change -6.94% -10.13%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $728.4K $741.7K
Total Long-Term Assets $0.00 $0.00
Total Assets $728.4K $741.7K
YoY Change -6.94% -10.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $100.00 $4.050K
YoY Change 0.0% 1.25%
Accrued Expenses $875.00
YoY Change -99.97%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.784M $3.658M
YoY Change -72.49% -35.03%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.784M $3.658M
Total Long-Term Liabilities
Total Liabilities $14.28M $14.16M
YoY Change 3.83% 3.87%
SHAREHOLDERS EQUITY
Retained Earnings -$18.82M -$18.69M
YoY Change 3.18% 3.38%
Common Stock $107.5K $107.5K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$13.56M -$13.42M
YoY Change
Total Liabilities & Shareholders Equity $728.4K $741.7K
YoY Change -6.94% -10.13%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$139.5K -$160.1K
YoY Change -17.84% -20.28%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$22.65K
YoY Change -71.37%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -$22.65K
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash -$22.65K
YoY Change -71.37%
FREE CASH FLOW
Cash From Operating Activities -$22.65K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3521006 usd
CY2024Q2 us-gaap Liabilities
Liabilities
14021006 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
107483 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5161532 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18525329 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-13256314 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
764692 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
3520906 usd
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107483450 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107483450 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107483450 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
764205 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
889405 usd
CY2024Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
9049000 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
875 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
0 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
3653235 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3658160 usd
CY2024Q3 us-gaap Convertible Debt
ConvertibleDebt
10500000 usd
CY2024Q2 us-gaap Convertible Debt
ConvertibleDebt
10500000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
14158160 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107483450 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107483450 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
107483 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5161532 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18685428 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-13416413 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
741747 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1540 usd
CY2024Q3 WEWA Rent Expense
RentExpense
75 usd
CY2023Q3 WEWA Rent Expense
RentExpense
45000 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
31075 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
28787 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
32690 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
74552 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-32690 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-74552 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
132329 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
132329 usd
CY2024Q3 us-gaap Interest Income Other
InterestIncomeOther
4920 usd
CY2023Q3 us-gaap Interest Income Other
InterestIncomeOther
6048 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-127409 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-126281 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-160099 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-200833 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107483450 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107483450 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107483450 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-13256314 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-160099 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-13416413 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-12604575 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-200833 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-12805408 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-160099 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-200833 usd
CY2024Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-300 usd
CY2023Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
14488 usd
CY2024Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3950 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3900 usd
CY2024Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
875 usd
CY2023Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0 usd
CY2024Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
132329 usd
CY2023Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
132329 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22645 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-79092 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-22645 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-79092 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
741560 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
810313 usd
CY2024Q3 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2015Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
6000000 shares
CY2015Q2 us-gaap Sale Of Stock Percentage Of Ownership After Transaction
SaleOfStockPercentageOfOwnershipAfterTransaction
0.738 pure
CY2015Q2 us-gaap Common Unit Issued
CommonUnitIssued
8130000 shares
CY2015Q2 us-gaap Common Unit Outstanding
CommonUnitOutstanding
8130000 shares
CY2015Q2 WEWA Sale Of Stock Number Of Share Issued In Transaction
SaleOfStockNumberOfShareIssuedInTransaction
340000 usd
CY2015Q2 WEWA Number Of Common Shares Sold Through Stock Purchase Agreement
NumberOfCommonSharesSoldThroughStockPurchaseAgreement
6000000 shares
CY2024Q3 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_z1nX5vcL4EKk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_864_z0lee0LaRBEi">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zbHVTu6uBO31" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_860_zj4w3Vevdhp4">Concentrations of Credit Risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company maintains our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. Accounts are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $<span id="xdx_904_eus-gaap--CashFDICInsuredAmount_iI_c20240831_zSwA4hdKLEm5" title="FDIC insured amount">250,000</span> under current regulations. The Company had approximately $<span id="xdx_90E_eus-gaap--CashUninsuredAmount_pp0p0_c20240831_zZHL2OONrIOd" title="Excess of FDIC insured limits">491,560</span> and $<span id="xdx_90F_eus-gaap--CashUninsuredAmount_pp0p0_c20240531_z5GbUlC6jAMa" title="Excess of FDIC insured limits">514,205</span> in excess of FDIC insured limits at August 31, 2024 and May 31, 2024, respectively. The Company has not experienced any losses in such accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
491560 usd
CY2024Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
514205 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18685428 usd
CY2024Q3 WEWA Working Capital
WorkingCapital
-2916413 usd
CY2024Q3 us-gaap Convertible Debt
ConvertibleDebt
10500000 usd
CY2024Q2 us-gaap Convertible Debt
ConvertibleDebt
10500000 usd
CY2024Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
10500000 usd
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2500000 usd
CY2024Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2024Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
8000000 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
132329 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
132329 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107483450 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107483450 shares
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001079973-24-001405-index-headers.html Edgar Link pending
0001079973-24-001405-index.html Edgar Link pending
0001079973-24-001405.txt Edgar Link pending
0001079973-24-001405-xbrl.zip Edgar Link pending
ex31x1.htm Edgar Link pending
ex32x1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wewa-20240831.xsd Edgar Link pending
wewa_10q-083124.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
wewa-20240831_cal.xml Edgar Link unprocessable
wewa-20240831_def.xml Edgar Link unprocessable
wewa-20240831_lab.xml Edgar Link unprocessable
wewa-20240831_pre.xml Edgar Link unprocessable
wewa_10q-083124_htm.xml Edgar Link completed